|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$25.11 |
$25.62 |
$24.79 |
$25.61 |
452.40K | 04/22/2024 |
$25.84 |
$26.99 |
$25.71 |
$26.61 |
296.30K | 04/23/2024 |
$26.65 |
$27.78 |
$26.61 |
$26.85 |
339.30K | 04/24/2024 |
$26.92 |
$27.61 |
$25.59 |
$25.70 |
326.50K | 04/25/2024 |
$25.13 |
$25.35 |
$24.51 |
$24.66 |
606.30K |
|
Protagonist Therapeutics is a clinical-stage biopharmaceutical company with various peptide-based new chemical entities in different stages of development, all derived from Co.'s proprietary technology platform. Co.'s clinical programs address two main categories of diseases; hematology and blood disorders, and inflammatory and immunomodulatory diseases. Co.'s main clinical asset, rusfertide (generic name for PTG-300) is an injectable hepcidin mimetic in development for the potential treatment of erythrocytosis, iron overload and other blood disorders. PN-943 is an investigational, orally delivered, gut-restricted alpha-4-beta-7 specific integrin antagonist for inflammatory bowel disease. | |
|
Protagonist Therapeutics (PTGX) has the following price history information. Looking back at PTGX historical stock prices for the last five trading days, on April 19, 2024, PTGX opened at $25.11, traded as high as $25.62 and as low as $24.79, and closed at $25.61. Trading volume was a total of 452.40K shares. On April 22, 2024, PTGX opened at $25.84, traded as high as $26.99 and as low as $25.71, and closed at $26.61. Trading volume was a total of 296.30K shares. On April 23, 2024, PTGX opened at $26.65, traded as high as $27.78 and as low as $26.61, and closed at $26.85. Trading volume was a total of 339.30K shares. On April 24, 2024, PTGX opened at $26.92, traded as high as $27.61 and as low as $25.59, and closed at $25.70. Trading volume was a total of 326.50K shares. On April 25, 2024, PTGX opened at $25.13, traded as high as $25.35 and as low as $24.51, and closed at $24.66. Trading volume was a total of 606.30K shares.
PTGX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Protagonist Therapeutics shares, starting with a $10,000 purchase of PTGX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
08/15/2016 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$11.50 |
|
End price/share: |
$24.66 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
114.43% |
|
Average Annual Total Return: |
10.42% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$21,449.08 |
|
Years: |
7.70 |
|
|
|
Date |
Close |
04/19/2024 | $25.61 | 04/22/2024 | $26.61 | 04/23/2024 | $26.85 | 04/24/2024 | $25.70 | 04/25/2024 | $24.66 |
|
|